Abstract
A trial of propranolol for the treatment of vasomotor symptoms was conducted among 37 menopausal women in a double-blind, placebo-controlled, crossover fashion. When compared with placebo, propranolol had a statistically significant effect on the reduction of both the frequency and severity of vasomotor symptoms (P<0.01). In selected patients, propranolol may be an alternative to the treatment of vasomotor symptoms with exogenous estrogens.
| Original language | English |
|---|---|
| Pages (from-to) | 356-364 |
| Number of pages | 9 |
| Journal | Clinical Therapeutics |
| Volume | 3 |
| Issue number | 5 |
| State | Published - 1981 |
Fingerprint
Dive into the research topics of 'Double-blind, placebo-controlled, crossover trial of propranolol as treatment for menopausal vasomotor symptoms'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver